NEW YORK, March 13, 2020 /PRNewswire/ -- Spherix
Incorporated today announced it has completed its name change to
AIkido Pharma Inc. and now trades under the ticker "AIKI".
The name change reflects company's increased focus on the use of
Artificial Intelligence and Machine Learning (AI and ML) in the
drug development space.
Anthony Hayes, CEO of AIkido,
stated, "This name change is the culmination of our transformation
to an innovative drug development company focused on leveraging the
power of AI/ML to accelerate drug development. The U.S. healthcare
system is at an important crossroads as it faces major demographic
shifts, burgeoning costs, and transformative technologies. AI/ML is
increasingly viewed as an answer, as evidenced using these
technologies to help address the Coronavirus outbreak. AIkido
Pharma Inc., with the use of the 'AI' in the name 'Aikido'
underscores our commitment to this evolution. In addition, AIkido
is a martial art known for using an opponent's efforts against that
opponent, alluding to our vision to develop technologies that
allows humans to use cancer's own attributes against the
disease."
About AIkido
AIkido, formerly known as Spherix, was initially formed in 1967
and is currently a biotechnology company with a diverse portfolio
of small-molecule anti-cancer therapeutics. The Company's
platform consists of patented technology from leading universities
and researchers and we are currently in the process of developing
an innovative therapeutic drug platform through strong partnerships
with world renowned educational institutions, including
The University of Texas at Austin and Wake
Forest University. Our diverse pipeline of therapeutics includes
therapies for pancreatic cancer, acute myeloid leukemia (AML) and
acute lymphoblastic leukemia (ALL). In addition, we are constantly
seeking to grow our pipe to treat unmet medical needs in
oncology.
Contact:
Investor
Relations:
Hayden IR
Brett Maas, Managing
Partner
Phone: (646) 536-7331
Email: brett@haydenir.com
www.haydenir.com
AIkido:
Phone: 212-745-1373
Email: investorrelations@spherix.com
www.spherix.com
View original
content:http://www.prnewswire.com/news-releases/spherix-completes-name-change-to-aikido-pharma-inc-301023121.html
SOURCE AIkido Pharma Inc.